In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
Chemomab Therapeutics Ltd ADR (NASDAQ: CMMB) closed the day trading at $2.53 up 4.55% from the previous closing price of $2.42. In other words, the price has increased by $4.55 from its previous closing price. On the day, 81421.0 shares were traded. CMMB stock price reached its highest trading level at $2.61 during the session, while it also had its lowest trading level at $2.415.
Ratios:
For a better understanding of CMMB, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 10.49 and its Current Ratio is at 10.49. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In the most recent recommendation for this company, Maxim Group on May 13, 2024, initiated with a Buy rating and assigned the stock a target price of $4.
On May 06, 2024, Oppenheimer Upgraded its rating to Outperform which previously was Perform but kept the price unchanged to $6.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CMMB now has a Market Capitalization of 15572446 and an Enterprise Value of 1235739648.
Stock Price History:
The Beta on a monthly basis for CMMB is 0.52, which has changed by -0.6675824 over the last 52 weeks, in comparison to a change of 0.12159383 over the same period for the S&P500. Over the past 52 weeks, CMMB has reached a high of $9.84, while it has fallen to a 52-week low of $2.36. The 50-Day Moving Average of the stock is -11.67%, while the 200-Day Moving Average is calculated to be -41.05%.
Shares Statistics:
Over the past 3-months, CMMB traded about 177.66K shares per day on average, while over the past 10 days, CMMB traded about 94990 shares per day. A total of 6.16M shares are outstanding, with a floating share count of 5.54M. Insiders hold about 9.98% of the company’s shares, while institutions hold 6.39% stake in the company. Shares short for CMMB as of 1763078400 were 16903 with a Short Ratio of 0.10, compared to 1760486400 on 67484. Therefore, it implies a Short% of Shares Outstanding of 16903 and a Short% of Float of 0.33000002.
Earnings Estimates
The performance of Chemomab Therapeutics Ltd ADR (CMMB) in the stock market is under the watchful eye of 1.0 analysts actively contributing to its current rating.The consensus estimate for the next quarter is -$0.04, with high estimates of -$0.04 and low estimates of -$0.04.
Analysts are recommending an EPS of between -$0.08 and -$0.08 for the fiscal current year, implying an average EPS of -$0.08. EPS for the following year is -$0.2, with 1.0 analysts recommending between -$0.2 and -$0.2.
